GlobeStar Therapeutics Corporation
GSTC
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00 | -- | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 83.80K | 147.70K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 83.90K | 147.70K | -- | -- | -- |
|
|
|||||
| Total Current Assets | 83.90K | 147.70K | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 83.90K | 147.70K | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 434.90K | 407.70K | 366.20K | 328.20K | 488.10K |
| Total Accrued Expenses | 882.70K | 810.20K | 731.40K | 680.00K | 667.20K |
| Short-term Debt | 303.40K | 308.00K | 306.60K | 306.30K | 40.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 25.60K | 28.40K | 68.70K | 59.70K | 15.90K |
| Total Finance Division Other Current Liabilities | 62.20K | 62.20K | 59.70K | 59.70K | 65.30K |
| Total Other Current Liabilities | 62.20K | 62.20K | 59.70K | 59.70K | 65.30K |
| Total Current Liabilities | 1.71M | 1.62M | 1.53M | 1.43M | 1.28M |
|
|
|||||
| Total Current Liabilities | 1.71M | 1.62M | 1.53M | 1.43M | 1.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 303.40K | 308.00K | 306.60K | 306.30K | 40.70K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.71M | 1.62M | 1.53M | 1.43M | 1.28M |
|
|
|||||
| Common Stock & APIC | 19.22M | 19.18M | 19.12M | 19.02M | 18.79M |
| Retained Earnings | -21.02M | -20.83M | -20.65M | -20.45M | -20.10M |
| Treasury Stock & Other | 179.00K | 179.00K | -- | -- | 32.50K |
| Total Common Equity | -1.63M | -1.47M | -1.53M | -1.44M | -1.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock Convertible | 100.00 | 100.00 | 100.00 | 100.00 | 600.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.10K | 1.10K | 1.10K | 1.10K | 1.60K |
|
|
|||||
| Total Common Equity | -1.63M | -1.47M | -1.53M | -1.44M | -1.28M |
| Total Preferred Equity | 1.10K | 1.10K | 1.10K | 1.10K | 1.60K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.62M | -1.47M | -1.53M | -1.43M | -1.28M |
|
|
|||||